Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab

  1. Hilario, A.
  2. Sepulveda, J.M.
  3. Hernandez-Lain, A.
  4. Salvador, E.
  5. Koren, L.
  6. Manneh, R.
  7. Ruano, Y.
  8. Perez-Nuñez, A.
  9. Lagares, A.
  10. Ramos, A.
Journal:
Clinical and Translational Oncology

ISSN: 1699-3055 1699-048X

Year of publication: 2017

Volume: 19

Issue: 1

Pages: 51-57

Type: Article

DOI: 10.1007/S12094-016-1502-4 GOOGLE SCHOLAR

Sustainable development goals